Cutler Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,800
Closed -$1K 6540
2021
Q4
$1K Buy
3,800
+2,500
+192% +$105K ﹤0.01% 5212
2021
Q3
$1K Hold
1,300
﹤0.01% 5511
2021
Q2
$1K Hold
1,300
﹤0.01% 5481
2021
Q1
$4K Sell
1,300
-2,900
-69% -$101K ﹤0.01% 4593
2020
Q4
$11K Sell
4,200
-4,400
-51% -$116K ﹤0.01% 3155
2020
Q3
$44K Buy
8,600
+3,800
+79% +$86.7K ﹤0.01% 1880
2020
Q2
$36K Buy
4,800
+1,400
+41% +$28.3K ﹤0.01% 1993
2020
Q1
$35K Sell
3,400
-62,200
-95% -$1.35M ﹤0.01% 1954
2019
Q4
$25K Buy
65,600
+5,200
+9% +$62.4K ﹤0.01% 2094
2019
Q3
$73K Buy
60,400
+59,400
+5,940% +$570K 0.01% 1270
2019
Q2
$2K Buy
+1,000
New +$12.8K ﹤0.01% 3689
2019
Q1
Sell
-41,900
Closed -$21K 5296
2018
Q4
$21K Buy
41,900
+8,800
+27% +$142K ﹤0.01% 2087
2018
Q3
$12K Sell
33,100
-2,900
-8% -$60.6K ﹤0.01% 2564
2018
Q2
$44K Buy
36,000
+2,200
+7% +$44.7K ﹤0.01% 1689
2018
Q1
$39K Buy
33,800
+2,200
+7% +$42.9K ﹤0.01% 1840
2017
Q4
$22K Sell
31,600
-41,400
-57% -$639K ﹤0.01% 2500
2017
Q3
$127K Buy
73,000
+31,700
+77% +$465K 0.01% 1473
2017
Q2
$13K Sell
41,300
-7,800
-16% -$90.4K ﹤0.01% 3913
2017
Q1
$182K Buy
49,100
+11,500
+31% +$166K 0.01% 1267
2016
Q4
$227K Sell
37,600
-6,600
-15% -$93.2K 0.01% 1207
2016
Q3
$279K Sell
44,200
-2,100
-5% -$84.9K 0.02% 965
2016
Q2
$81K Buy
46,300
+21,400
+86% +$769K 0.01% 1890
2016
Q1
$261K Buy
24,900
+16,900
+211% +$563K 0.02% 859
2015
Q4
$39K Buy
+8,000
New +$404K ﹤0.01% 2734

Other funds holding ITCI